Literature DB >> 32710973

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.

Zita-Rose Manjaly Thomas1, Anne Leuppi-Taegtmeyer2, Dagmar Jamiolkowski3, Esther Steveling-Klein1, Felicitas Bellutti-Enders4, Kathrin Scherer Hofmeier1, Karin Hartmann5.   

Abstract

Entities:  

Keywords:  Acute respiratory syndrome; COVID-19; SARS-CoV-2; adverse drug reactions; coronavirus; drug allergy; drug hypersensitivity; remdesivir

Mesh：

Substances：

Year:  2020        PMID： 32710973     DOI： 10.1016/j.jaci.2020.07.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.

Authors:  Mohitosh Biswas; Nares Sawajan; Thanyada Rungrotmongkol; Kamonpan Sanachai; Maliheh Ershadian; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

2.  Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.

Authors:  Katarzyna Szajek; Marie-Elisabeth Kajdi; Valerie A Luyckx; Thomas Hans Fehr; Ariana Gaspert; Alexia Cusini; Karin Hohloch; Philipp Grosse
Journal:  BMC Nephrol       Date:  2021-01-08       Impact factor: 2.388

3.  Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19.

Authors:  Shengyong Wu; Zhichao Jin; Chi Peng; Dongdong Li; Yi Cheng; Ronghui Zhu; Jia He; Cheng Wu
Journal:  J Glob Health       Date:  2022-02-19       Impact factor: 4.413

Review 4.  Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy.

Authors:  Manali Singh; Kuldeep Jayant; Dipti Singh; Shivani Bhutani; Nitesh Kumar Poddar; Anis Ahmad Chaudhary; Salah-Ud-Din Khan; Mohd Adnan; Arif Jamal Siddiqui; Md Imtaiyaz Hassan; Faez Iqbal Khan; Dakun Lai; Shahanavaj Khan
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

5.  Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients.

Authors:  Yasutaka Mitamura; Daniel Schulz; Saskia Oro; Nick Li; Isabel Kolm; Claudia Lang; Reihane Ziadlou; Ge Tan; Bernd Bodenmiller; Peter Steiger; Angelo Marzano; Nicolas de Prost; Olivier Caudin; Mitchell Levesque; Corinne Stoffel; Peter Schmid-Grendelmeier; Emanual Maverakis; Cezmi A Akdis; Marie-Charlotte Brüggen
Journal:  Allergy       Date:  2021-07-19       Impact factor: 14.710
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.